ziv-aflibercept
REGENERON-VGFT-ST-0202
Phase 1 mab completed
Quick answer
ziv-aflibercept for Cancer is a Phase 1 program (mab) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed